Prosonix
- Tel: +44 (0) 1865 784242
- Contact this Company »
- Visit Web Site »
Prosonix based in Oxford UK are world leaders in ultrasonic process chemistry at commercial scale and in particular have extensive experience in solving both complex and common crystallization problems via sonocrystallization.
Prosonix successful licensing business model has delivered over 30 collaborations, 3 commercial scale equipment supply contracts, and 8 license agreements to date including those recently concluded with UCB (Belgium) and Alcoa World Alumina (Australia).
Prosonix has overcome these significant engineering hurdles and made that academic curiosity a commercial reality. Industry is only just beginning to realise the tremendous latent potential for commercial scale sonocrystallization, sonoprocessing, sonochemistry and the new field of Sonobiocatalysis™.
Our proprietary process and ProsonitronTM reactor technology harnesses the power of acoustic cavitation given by high intensity power ultrasound, and is already proven across scale and in a range of industrial environments, including pharmaceuticals, high value mineral processing and the energy sector.
In a new and exciting development in the energy sector, our technology has the potential to improve the operational efficiency and lifetimes of oil platforms and fields with concurrent significant environmental benefits, and we are undertaking a rapid commercialisation program. This application also has translational benefits in a number of different industry segments.
Other significant opportunities exist in foods, environmental processing, specialty and performance chemicals, hydrometallurgy, and renewable energy sources to name but a few.
Finally our teams commercialisation success to date is evidenced by our customers success which are embodied in our collaborative development, equipment supply, and license deals, and moreover the trust which our innovation partners place in us to take our joint developments to market.
Prosonix Limited
Magdalen Centre
Robert Robinson Avenue
Oxford Science Park
Oxford, OX4 4GA
UK David Hipkiss
CEO
Tel: +44 (0) 1865 784250
Fax: +44 (0) 1865 784251
Web: www.prosonix.co.uk
Particle Engineering
- Sound Science And Crystals »
Improved Crystallization and Particle Engineering.
Global Innovation Award
- CrystalGEMTM Wins Global Innovation Award »
Prosonix Ltd (Oxford UK) and Chiralabs (Kidlington, Oxon, UK) unique CrystalGEMTM Predictive Crystallization Technology has won the Gold Award for Innovation at this years CPhI 2005 Worldwide tradeshow in Madrid, beating 6 other major international corporations in the process.
Pharmaceutical Crystallisation
- Controlling crystallisation of pharmaceutical ingredients »
Graham Ruecroft
Pharmaceutical Crystallisation has been described as one of the most difficult unit operations to control.
Complete Crystallisation Control
- Complete Crystallisation Control™ »
Traditionally one of the most difficult unit operations to control, crystallisation plays an enormous part in industry today, since almost all chemical processes that produce solid material utilise at least one crystallisation process, either to aid purification or control the physical form of the product.
Ultrasonic Technology
- Prosonix and CBC In Marketing Agreement for Proprietary Ultrasonic Technology in Japan »
Prosonix Ltd, (Oxford, UK) and CBC Co. Ltd (Tokyo, Japan, hereinafter CBC), announce the renewal of an agreement to cover the commercialisation of Prosonix patented sonoprocessing technology.
Sonocrystallization Technology
- Proprietary Sonocrystallization Technology »
Prosonix Announce The Signing of a License Agreement For World Wide Exploitation of Proprietary Sonocrystallization Technology
Particle Engineering Technology
- Prosonix and University of Bath Sign Agreement for World Beating SAXTM Particle Engineering Technology »
Prosonix Limited (Oxford, UK) is delighted to announce an agreement with the University of Bath (Bath, UK) for the exclusive commercialisation of the University's unique sonocrystallization particle engineering technology Solution Atomisation and Crystallization by Sonication (SAXTM).
Sonocrystallization Agreement
- Prosonix and UCB Extend Co-development Agreement for Prosonix Sonocrystallization Technology »
Prosonix Ltd (Oxford UK) and UCB SA (Braine l'Alleud, Belgium), are pleased to announce the extension of their Co-Development and Licensing Agreement for the utilization of Prosonix' proprietary sonocrystallization technology across a range of its pharmaceutical products.
Predictive Crystallization Technology
- CrystalGEM™: Award Winning Predictive Crystallization Technology »
The optimum crystallization screening methodology for pharmaceuticals
Micronisation Techniques
- SAX™: The Ultimate In Particle Engineering »
A new micronisation technique from Prosonix
Ultrasonic Process Chemistry
- World Leaders In Ultrasonic Process Chemistry »
Applications and developments in ultrasonic process chemistry
